A real-world clinical study of camrelizumab in the treatment of esophageal cancer.

被引：0
|
作者：
Sun, Guoping
Qian, Dong
Zhao, Dong
Liang, Hui
Cheng, Huaidong
Wang, Genhe
Wang, Fan
Jiang, Hao
Xu, Tengyun
Wu, Qibing
Zhu, Shaojin
Xu, Dong
机构：
[1] Anhui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China
[2] Univ Sci & Technol China, Affiliated Hosp 1, Hefei, Peoples R China
[3] Lixin Cty Peoples Hosp, Lixin, Peoples R China
[4] Tradit Chinese Hosp Luan, Luan, Peoples R China
[5] Anhui Med Univ, Affiliated Hosp 2, Hefei, Peoples R China
[6] Huangshan City Peoples Hosp, Huangshan, Peoples R China
[7] Bengbu Med Coll, Affiliated Hosp 1, Bengbu, Peoples R China
[8] USTC, Dept Oncol, Affiliated Hosp 1, Hefei, Peoples R China
[9] Yijishan Hosp, Wannan Med Coll, Affiliated Hosp 1, Wuhu, Peoples R China
[10] Wannan Med Coll, Affiliated Hosp 1, Wuhu, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e16008
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16008
引用
收藏
页数：3
相关论文
共 50 条
  • [31] A Real-World Study on Oral Vinorelbine for the Treatment of Metastatic Breast Cancer
    Huang, Jiayi
    Bai, Xue
    Xie, Xiaofeng
    Chen, Liping
    Lan, Xiaofeng
    Zhang, Qiuyi
    Song, Lin
    Hong, Pengjiao
    Du, Caiwen
    ONCOLOGIE, 2022, 24 (01) : 131 - 145
  • [32] A randomized clinical study of surgery versus radiotherapy in the treatment of resectable esophageal cancer.
    Yu, J.
    Ren, R.
    Sun, X.
    Yin, Y.
    Fu, Z.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 181S - 181S
  • [33] Safety and efficacy of neoadjuvant treatment with immune checkpoint inhibitors in esophageal cancer: real-world multicenter retrospective study in China
    Yang, Yang
    Tan, Lijie
    Hu, Jian
    Li, Yin
    Mao, Yousheng
    Tian, Ziqiang
    Zhang, Baihua
    Ma, Jianqun
    Li, Hecheng
    Chen, Chun
    Chen, Keneng
    Han, Yongtao
    Chen, Longqi
    Liu, Junfeng
    Yu, Bentong
    Yu, Zhentao
    Li, Zhigang
    DISEASES OF THE ESOPHAGUS, 2022, 35 (11)
  • [34] Real-world study: from real-world data to real-world evidence
    Wen, Yi
    TRANSLATIONAL BREAST CANCER RESEARCH, 2020, 1
  • [35] Safety and efficacy of apatinib for non-surgical advanced esophageal cancer: A real-world study
    Sun, C.
    Zhang, B.
    Chen, M.
    Li, J.
    Liu, Y.
    Hu, A.
    Ma, W.
    Mu, Y.
    Zhuang, Q.
    Zou, B.
    Li, B.
    ANNALS OF ONCOLOGY, 2021, 32 : S147 - S147
  • [36] The essence of real-world study in cancer research
    Li, Chen
    Zang, Jian
    Li, Fan
    Hu, Haixia
    Wang, Ling
    Xia, Jielai
    TRANSLATIONAL BREAST CANCER RESEARCH, 2020, 1
  • [37] Neoadjuvant Camrelizumab for Non-Small Cell Lung Cancer: A Retrospective Multicenter, Real-World Study (CTONG2004)
    Si-Yang Liu
    Qixun Chen
    Chengzhi Zhou
    Huizhong Zhang
    Wen Li
    Jianhua Chen
    Jian Hu
    Lin Wu
    Qunqing Chen
    Qiangsheng Dai
    Jian-Zhen Shan
    Fei Xu
    Si-Yang Maggie Liu
    Yi-Long Wu
    Cancer Immunology, Immunotherapy, 2023, 72 : 2257 - 2265
  • [38] Comparison of the efficacy and safety of domestically produced tislelizumab, camrelizumab, and imported pembrolizumab in the treatment of advanced NSCLC: a real-world retrospective study
    Hu, Jia
    Li, Mengting
    Xie, Zeyu
    Chen, Jisheng
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, : 204 - 212
  • [39] Unicentric real-world data from esophageal cancer neoadjuvant treatment according to the CROSS trial protocol
    Mendonca, J.
    Silva, C.
    Calcada, C.
    Fardilha, C.
    Gagean, J.
    Costa, P.
    ANNALS OF ONCOLOGY, 2021, 32 : S129 - S130
  • [40] Neoadjuvant Camrelizumab for Non-Small Cell Lung Cancer: A Retrospective Multicenter, Real-World Study (CTONG2004)
    Liu, Si-Yang
    Chen, Qixun
    Zhou, Chengzhi
    Zhang, Huizhong
    Li, Wen
    Chen, Jianhua
    Hu, Jian
    Wu, Lin
    Chen, Qunqing
    Dai, Qiangsheng
    Shan, Jian-Zhen
    Xu, Fei
    Liu, Si-Yang Maggie
    Wu, Yi-Long
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (07) : 2257 - 2265
12345